James W. Brush
InvestorGeneral Partner and Portfolio Manager at Frazier Life Sciences · General Partner at Frazier Healthcare Partners
Palo Alto
About
Jamie is a General Partner and Portfolio Manager at Frazier Life Sciences, which he joined in 2016, investing in private and public biotechnology companies. He co-leads Frazier's public equity investment strategy and serves as co-Portfolio Manager of the Frazier Life Sciences Public Fund alongside Albert Cha. Before Frazier, he was a management consultant at the Boston Consulting Group within its Healthcare Practice, and he holds an M.D. from the University of Southern California and a B.A. from Middlebury College.
Invests in
Biotech
Experience
- Frazier Life SciencesGeneral Partner and Portfolio Managercurrent2016 — presentPalo Alto, California, United States
- The Boston Consulting GroupConsultant2014 — 2016Greater Boston Area
- Beth Israel Deaconess Medical CenterResident in Internal Medicine, Harvard Medical School2011 — 2014
- Harvard Medical SchoolResearch Assistant2005 — 2007
Education
- University of Southern CaliforniaM.D.2007 — 2011
- Middlebury CollegeB.A.2001 — 2005
Skills & more
+12 more
ResearchHealthcareProtein ChemistryImmunologyMolecular BiologyHospitalsBiomedicineDNANeuroscienceGeneticsBiotechnologyClinicalLanguages English
From James's professional profile.
Same school
Also attended University of Southern California374
+ 368 more
Also attended Middlebury College102
+ 96 more
Shared employers
Also worked at Frazier Life Sciences46
+ 40 more
Also worked at The Boston Consulting Group737
+ 731 more
Also worked at Beth Israel Deaconess Medical Center25
+ 19 more
Also worked at Harvard Medical School124
+ 118 more
Deals · 1
Amunix Pharmaceuticals, Inc.Board seat
via Frazier Life Sciences · filed Mar 2020 · $83.6M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Frazier Life Sciences
Network2
Investors connected to James in public investor directories — a warm-intro map.